Bill Nygren’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517K Sell
431
-19
-4% -$19.4K ﹤0.01% 133
2026
Q1
$414K Buy
450
+36
+9% +$36.5K ﹤0.01% 137
2025
Q4
$445K Hold
414
﹤0.01% 139
2025
Q3
$316K Hold
414
﹤0.01% 139
2025
Q2
$323K Buy
+414
New +$322K ﹤0.01% 141
2015
Q2
Sell
-3,100
Closed -$225K 151
2015
Q1
$225K Sell
3,100
-710
-19% -$50.5K ﹤0.01% 164
2014
Q4
$263K Buy
3,810
+110
+3% +$7.42K ﹤0.01% 173
2014
Q3
$240K Hold
3,700
﹤0.01% 169
2014
Q2
$230K Hold
3,700
﹤0.01% 175
2014
Q1
$218K Buy
+3,700
New +$206K ﹤0.01% 176

Other funds holding LLY

Bill Nygren's LLY Position: Q2 2026 in Review

Bill Nygren reduced its Eli Lilly (LLY) stake by 4.2% in Q2 2026, selling an estimated $19.4K and leaving 431 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #133.

Bill Nygren first reported a position in LLY in Q1 2014 and has held it in 10 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bill Nygren held 431 shares of Eli Lilly worth $517K as of Q2 2026.
  • Bill Nygren sold 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up ﹤0.01% of Bill Nygren's portfolio in Q2 2026, its #133 holding.
  • Bill Nygren first reported a position in Eli Lilly in Q1 2014 and has held it in 10 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harris Associates's 13F filing for Q2 2026, filed 14 Aug 2026.